MedMira Awarded China Patent

Rapid Flow-Through Technology Patents in Three Major Global Markets

25-Jul-2008

MedMira Inc. announced that it received a Notice on Grant of Patent Right For Invention (equivalent to the Notice of Allowance in the United States) from the State Intellectual Property Office (SIPO) of the People's Republic of China for its rapid diagnostic device and assay (Chinese Patent Application No. 02819646.5). The novel invention is the rapid flow-through technology (RFT) platform, the core product engine upon which the company has built its successful line of rapid tests for diseases such as HIV and Hepatitis. This patent rounds out MedMira's IP "triple crown" along with similar patents awarded in the United States (Patent Application No. 10/163,675) and the European Union (European Patent No. EP1417489).

"Patents on our core technology in three major global markets are fundamental components of our plan to grow our business through strategic partnerships. While we continue to pursue patent protection for our progressive IP estate in additional markets, we can now fully engage in collaborative relationships to tap opportunities in three of the most lucrative markets of the $40 billion global diagnostics market," said Hermes Chan, President and CEO, MedMira Inc. "These partnerships, taking shape in various forms including licensing, commercialization, and contract manufacturing, will enable both new business and new innovation opportunities for MedMira."

Other news from the department research and development

Most read news

More news from our other portals

So close that even
molecules turn red...

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures
View topic world
Topic world Diagnostics

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures